Pharmaceutical Technology
MARCH 17, 2023
Over the last twenty years, there has been a major rise in risk sharing agreements in the pharmaceutical space, said Alex Watt, GlobalData’s principal research analyst, at a recent webinar on the same topic. Thus, a higher risk score reflects a more hostile market access environment and drug launch in a geographical area.
Roots Analysis
FEBRUARY 23, 2024
These experts are like the superhero squad for medical research. With the rising demand for antibody therapeutics in the recent past, the domain of antibody discovery has seen a significant market growth towards outsourcing. Companies are now turning to contract research organizations to help accelerate their workflow.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Pharma Data
AUGUST 20, 2020
It has since expanded nationwide, threatening an important market for many Big Pharma players. . At the time, Wolfe Research analyst Tim Anderson wondered whether the decline was the “canary in the coalmine” for the rest of the industry, which has been relying on the lucrative China market for revenue growth.
XTalks
APRIL 13, 2021
New data from the Plant Based Foods Association (PBFA) and The Good Food Institute (GFI) shows that the retail sales of plant-based foods in the US grew by 27 percent in 2020, bringing its total market value to $7 billion. of the $7 billion market. Plant-Based Milk Sales. Plant-Based Meat Sales. billion in sales in 2020.
Roots Analysis
JANUARY 23, 2024
The peptide therapeutics market has undergone substantial evolution since the inception of insulin. Presently, over 80 peptide-based drugs are available in the market for myriad of disorders and diseases. Presently, over 80 peptide-based drugs are available in the market for myriad of disorders and diseases.
ACRP blog
NOVEMBER 8, 2023
“With retail pharmacies entering the clinical trial space, investigative sites are left with little information around how this move will affect them or their patients,” says Emily Botto, Senior Research Analyst at the Tufts Center for the Study of Drug Development (CSDD) and a scheduled presenter at the ACRP 2024 conference in Anaheim, Calif.
Pharmaceutical Technology
JANUARY 27, 2023
Dr. James George, a research professor at the University of Oklahoma Health Sciences Center, said Cablivi “adds a new aspect to treatment, the prompt recovery of platelets and prompt resolution of transient neurologic symptoms”. The disorder has a reported annual incidence between 1.5 cases per million in Europe.
Expert insights. Personalized for you.
257 
Let's personalize your content